Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). (Q33389637)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

object named as

Peter Bramlage

8

0 references

author name string

Hanno Riess

1

1 reference

Europe PubMed Central

26 July 2017

Uwe Pelzer

2

1 reference

Europe PubMed Central

26 July 2017

Andreas Hilbig

3

1 reference

Europe PubMed Central

26 July 2017

Jens Stieler

4

1 reference

Europe PubMed Central

26 July 2017

Bernhard Opitz

5

1 reference

Europe PubMed Central

26 July 2017

Theo Scholten

6

1 reference

Europe PubMed Central

26 July 2017

Dörte Kauschat-Brüning

7

1 reference

Europe PubMed Central

26 July 2017

Bernd Dörken

9

1 reference

Europe PubMed Central

26 July 2017

Helmut Oettle

10

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

5 December 2008

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

8

1 reference

Europe PubMed Central

26 July 2017

361

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-361

0 references

Coagulation, anticoagulation and pancreatic carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Cancer statistics, 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Pancreatic cancer and thromboembolic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Two patients with arterial thromboembolism among 311 patients with adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Molecular basis for the relationship between thrombosis and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Complete clinical remission in a patient with advanced pancreatic cancer using mitomycin C-based chemotherapy: the role of adjunctive heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Spontaneous arterial thrombosis in association with pancreatic carcinoma: diagnosis and interventional management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

31 October 2018

A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

31 October 2018

Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

31 October 2018

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimates of cancer incidence and mortality in Europe in 1995

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in relative risk of venous thromboembolism in different cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of metastatic non-small cell lung cancer with low molecular weight heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral Anticoagulation in patients with gynecological cancer and radiotherapy: a retrospective analysis of 132 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the pancreas; diagnostic and operative criteria based on 100 consecutive autopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the pancreas; effect of histological types and grade of malignancy on its behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-361

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33389637&oldid=1644380775"